Rodrigo Santacruz
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis.
Journal: Blood cancer journal
Published: October 03, 2015
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
Journal: British journal of haematology
Published: July 11, 2015
Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML.
Journal: Leukemia research
Published: March 01, 2015
Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
Journal: Haematologica
Published: July 06, 2014
New treatment options for chronic lymphocytic leukemia.
Journal: Expert opinion on pharmacotherapy
Published: February 25, 2014
Skin lesions in a patient with blastic plasmacytoid dendritic cell neoplasm.
Journal: British journal of haematology
Published: December 31, 2013
Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 11, 2013
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion.
Journal: British journal of haematology
Published: April 10, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026